SG140586A1 - Methods - Google Patents

Methods

Info

Publication number
SG140586A1
SG140586A1 SG200800987-0A SG2008009870A SG140586A1 SG 140586 A1 SG140586 A1 SG 140586A1 SG 2008009870 A SG2008009870 A SG 2008009870A SG 140586 A1 SG140586 A1 SG 140586A1
Authority
SG
Singapore
Prior art keywords
polypeptide
taz
amount
nucleic acid
acid encoding
Prior art date
Application number
SG200800987-0A
Inventor
M Zakir Hossain
Walter Hunziker
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Priority to SG200800987-0A priority Critical patent/SG140586A1/en
Publication of SG140586A1 publication Critical patent/SG140586A1/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Methods A non-human animal which has a reduced amount of functional TAZ polypeptide and/or TAZ-like polypeptide, or a reduced amount of nucleic acid encoding said polypeptide. A method for generating a non-human animal which develops PKD comprising reducing the amount of functional TAZ polypeptide and/or TAZ- like polypeptide, or nucleic acid encoding said polypeptide. A method of screening for compounds of use in preventing or treating PKD wherein a non- human animal is administered with a test compound and the effect of the test compound on the amount or function of TAZ polypeptide and/or a TAZ-like polypeptide and/or a polypeptide regulated by TAZ or a TAZ-like polypeptide function, or the amount of nucleic acid encoding said polypeptide, is assessed. (Figure 1)
SG200800987-0A 2004-08-04 2004-08-04 Methods SG140586A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG200800987-0A SG140586A1 (en) 2004-08-04 2004-08-04 Methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG200800987-0A SG140586A1 (en) 2004-08-04 2004-08-04 Methods

Publications (1)

Publication Number Publication Date
SG140586A1 true SG140586A1 (en) 2008-03-28

Family

ID=39205062

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200800987-0A SG140586A1 (en) 2004-08-04 2004-08-04 Methods

Country Status (1)

Country Link
SG (1) SG140586A1 (en)

Similar Documents

Publication Publication Date Title
BRPI0517091B8 (en) 4-hydroxybenzomorphan compound 3-substituted by carboxamide or thiocarboxamide
HK1160388A1 (en) Methods of diagnosing and treating complications of pregnancy
TNSN07113A1 (en) Cupredoxin derived transport agents and methods of use thereof
BRPI0516727A (en) methods for treating a cd30 positive lymphoma, for inhibiting the growth of a cd30 expressing cell, and for treating or preventing a disease
DE602004012881D1 (en) Cst (compartmentalised self tagging)
MXPA05006629A (en) Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer.
MXPA05005069A (en) Application system with recycle and related use of antimicrobial quaternary ammonium compound.
DE60122337D1 (en) USE OF TACI AS ANTITUMORING AGENT
DE502004012162D1 (en) ELECTROSTERLY STABILIZED AQUEOUS POLYURETHANE RESINS, PROCESS FOR THEIR PREPARATION AND THEIR USE
DE602005002164D1 (en) Polishing composition and polishing method
EP1475709A3 (en) Method and system for controlling privileges in an operating system
WO2004067728A3 (en) Methods and systems for the identification of rna regulatory sequences and compounds that modulate their function
TW200600515A (en) Composition and method for producing same
DE602004019197D1 (en) CONTENT DISTRIBUTION SYSTEM WITH INTEGRATED RECORD CONTROL
TW200616553A (en) Stabilized pancreas product
AU2003294782A8 (en) Method for providing natural therapeutic agents with high therapeutic index
BRPI0507559A (en) effluent treatment
EP1254260A4 (en) Methods for diagnosing and treating heart disease
SG140586A1 (en) Methods
WO2003074652A3 (en) Methods for identifying agents that modulate mast cell degranulation
WO2004007686A3 (en) Methods and transgenic mouse model for identifying and modulating factors involved in the production of reactive oxygen intermediates
WO2003087054A3 (en) Methods for identifying compounds that modulate enzymatic activity
MY155329A (en) Natural rubber latex
NZ593652A (en) Two-part code to determine data associated with the code
EP1363528A4 (en) Methods for diagnosing and treating heart disease